The Patent Finder

Purepharm Inc.

Also on record
Records under this name other than the patents Purepharm Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Showing 1 to 5 of 5 · Back to Purepharm Inc.

PatentTitleStatus Expires Confidence
US 7,060,289Topical glycopyrrolate product
Term ended
Term ended May 8, 2022 · From the USPTO record
Term endedTerm ended May 8, 2022From the USPTO record
US 8,679,524Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating
Term ended
Ended no later than May 8, 2022 · From the USPTO record
Term endedEnded no later than May 8, 2022From the USPTO record
US 9,034,368Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating
Term ended
Ended no later than May 8, 2022 · From the USPTO record
Term endedEnded no later than May 8, 2022From the USPTO record
US 8,252,316Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating
Lapsed on the fee record
Ended Aug 28, 2020 · From the USPTO record
Lapsed on the fee recordEnded Aug 28, 2020From the USPTO record
US 7,448,385Nasal adaptation of an oral inhaler device
Lapsed on the fee record
Ended Nov 11, 2016 · From the USPTO record
Lapsed on the fee recordEnded Nov 11, 2016From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited